BioCorRx (BICX) Non-Current Deferred Revenue (2012 - 2024)
BioCorRx (BICX) recorded Non-Current Deffered Revenue of $4,045 in Q1 2024, unchanged from $4,045 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Non-Current Deferred Revenue (2012 - 2024) Analysis & Trends
Starting with Q4 2013, BioCorRx's Non-Current Deffered Revenue history includes 40 quarters.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -54.5% (FY2018 to FY2023).
- Across earlier years, Non-Current Deffered Revenue came in at $4,045 in FY2022 (-89.2%), $37,301 in FY2021 (-48.4%), $72,281 in FY2020 (-30.0%) and $103,313 in FY2019 (-50.2%).
- Quarterly Non-Current Deffered Revenue has ranged from $4,045 in Q4 2022 to $168,563 in Q2 2019 over the past five years.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 0.0% (Q1 2024) to 89.2% (Q4 2022).
- Per Business Quant, the preceding three quarters came in at $4,045 (Q4 2023), $4,045 (Q3 2023) and $4,045 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BioCorRx | 830.00 | -906,148.00 | -56,997.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 4,045.00 |
| Sep 30, 2023 | 4,045.00 |
| Jun 30, 2023 | 4,045.00 |
| Mar 31, 2023 | 4,045.00 |
| Dec 31, 2022 | 4,045.00 |
| Sep 30, 2022 | 11,137.00 |
| Jun 30, 2022 | 19,954.00 |
| Mar 31, 2022 | 28,675.00 |
| Dec 31, 2021 | 37,301.00 |
| Sep 30, 2021 | 46,118.00 |
| Jun 30, 2021 | 54,935.00 |
| Mar 31, 2021 | 63,656.00 |
| Dec 31, 2020 | 72,281.00 |
| Sep 30, 2020 | 78,402.00 |
| Jun 30, 2020 | 87,219.00 |
| Mar 31, 2020 | 94,592.00 |
| Dec 31, 2019 | 103,313.00 |
| Sep 30, 2019 | 139,604.00 |
| Jun 30, 2019 | 168,563.00 |
API Access
BioCorRx Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();